Document Detail


Protease inhibitor use in 233 pregnancies.
MedLine Citation:
PMID:  16123678     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In the United States, as most highly active antiretroviral therapy (HAART) regimens used during pregnancy in HIV-infected women include a protease inhibitor (PI), it is important to determine the effects of PIs specifically rather than all HAART regimens. Prospective trials employing HAART during pregnancy are ongoing. OBJECTIVE: To better understand the effects of PI use during pregnancy on prematurity, maternal and infant adverse events, and infant outcomes. RESULTS: A total of 233 pregnancies in which PIs were used were reported, including 5 sets of twins and 1 set of triplets. Perinatal transmission is documented in 2 of 221 infants for a rate of 0.9% (95% CI, 0%-2.2%). Both HIV-positive infants were delivered by cesarean section (one elective at 37 1/7 weeks and one unscheduled at 32 6/7 weeks). The prematurity rate (<37 weeks' gestation) was 22.0% (95% CI, 16.9%-28.0%) including 3 twin and 1 triplet pregnancies. In multiple regression analysis no association was noted for individual PIs or the week of gestation that PIs were initiated. Adverse maternal, obstetric, and infant events possibly related to PIs were uncommon. CONCLUSIONS: In this series, PIs during pregnancy appeared generally safe for mothers and infants. Perinatal transmission was low and the prematurity rate is similar to prior data in HIV-positive women not on PIs.
Authors:
Anne B Morris; Ana Rua Dobles; Susan Cu-Uvin; Carmen Zorrilla; Jean Anderson; Joseph I Harwell; Jean Keller; Jane Garb
Related Documents :
12738118 - Successful outcome after serial amnioreductions in triplet fetofetal transfusion syndrome.
15136118 - Multifetal pregnancy reduction of triplet and higher-order multiple pregnancies to twins.
23440818 - Intramuscular versus intravenous anti-d for preventing rhesus alloimmunization during p...
23970458 - Gonadotrophins for idiopathic male factor subfertility.
3162508 - Changes in the concentrations of prostaglandins e and f in the utero-placental tissues ...
10799398 - Protein metabolism in pregnancy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  40     ISSN:  1525-4135     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-26     Completed Date:  2005-11-02     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  30-3     Citation Subset:  IM; X    
Affiliation:
Community Research Initiative of New England, Springfield, MA 01107, USA. amorris@crine.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
CD4 Lymphocyte Count
Cesarean Section
Cohort Studies
Female
HIV / isolation & purification
HIV Infections / drug therapy*,  immunology,  prevention & control*,  transmission,  virology
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical / prevention & control*
Pregnancy
Pregnancy Complications, Infectious / drug therapy*,  immunology,  prevention & control*,  virology
Premature Birth
Protease Inhibitors / administration & dosage*
Retrospective Studies
Treatment Outcome
Triplets
Twins
Viral Load
Chemical
Reg. No./Substance:
0/Protease Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after sin...
Next Document:  HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with det...